Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Hairgain® significantly increased hair growth and was well-tolerated by individuals with hair loss.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

In a Tuscan pediatric clinic, 7.19% of children had hair or scalp disorders, with nonscarring alopecia being the most common.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Advanced platelet-rich fibrin improves healing and reduces pain in oral surgery.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Topical vitamin D is effective in treating vitiligo with few side effects.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Alopecia areata may be influenced by both genetics and environment, requiring family monitoring and addressing stress and infections.

Zinc and iron levels drop after bariatric surgery, needing careful monitoring and supplements.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Rosemary essential oil can improve mood, sleep, and cognitive function but may cause allergies, so use it carefully.

Exosome therapies improve skin and hair rejuvenation effectively.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

The device safely increased hair growth and thickness in men with hair loss.

Bimatoprost effectively improves eyelashes in chemotherapy patients.

AI-personalized hair loss treatments improved hair growth and scalp health without side effects.

Electrochemotherapy successfully treated skin tumors in cats without recurrence.

Tailored combination therapy improves non-scarring alopecia outcomes.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Removing ingrown hairs can significantly improve persistent kerion in children.

Early and accurate identification of primary scarring alopecias is crucial to prevent permanent hair loss.

Low-dose oral minoxidil is safe for treating children's hair disorders.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Platelet-rich plasma therapy helps increase hair density in male patients with hair loss but doesn't change hair thickness.